ArticleBMC pediatrics2025
Three decades of progress: evolution of outcomes and prognostic indicators in biliary atresia management.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Dynamic landmark models predicting native liver survival after kasai portoenterostomy: a bicentric study.Pediatric surgery international · 2026Article
- The characteristics of liver nodules in biliary atresia native liver survivors.Pediatric surgery international · 2026Article
- Early Living Donor Liver Transplant Is Associated With Improved Graft- and Patient-Survival Outcomes in Children With Biliary Atresia.Pediatric transplantation · 2026Article
- Redefining the albumin-bilirubin score: Predictive modeling and multidimensional integration in liver and systemic disease.World journal of gastroenterology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBiliary atresia (BA) remains a challenging condition with variable outcomes following Kasai portoenterostomy (KPE). This study evaluates the predictive value of three scoring systems (ALBI, APRI, and METAVIR) for prognostication and analyzes three decades of treatment outcomes at a single institution.
methodsRecords of 96 BA patients who underwent KPE between 1990 and 2022 were retrospectively analyzed. Patients were stratified by preoperative ALBI (originally developed for HCC but applied here for its objective assessment of liver function), preoperative and postoperative APRI, and METAVIR scores. Treatment eras were divided into 1990-2000 (n = 18), 2001-2010 (n = 31), and 2011-2022 (n = 47). Clearance of jaundice was assessed at three months post-KPE, following established literature benchmarks. Kaplan-Meier curves and Log-Rank tests were used for survival analyses with a median follow-up of 5.1 years (range: 1-10 years).
resultsThe 10-year native liver survival (NLS) rate was 52.4%, with overall survival (OS) of 69.6%. Preoperative ALBI and APRI scores showed limited prognostic value (p = 0.12 and p = 0.17, respectively). However, postoperative APRI scores exceeding 1.12 at three months significantly predicted poor outcomes (p = 0.00094). METAVIR scores demonstrated poor correlation with long-term outcomes (p = 0.26). Analysis across treatment eras revealed significant improvement, with NLS increasing from 42.1 to 64.8% (p = 0.0029) and OS from 56.3 to 85.2% (p < 0.0001) between 1990 and 2000 and 2011-2022. Among the 52 patients with completed 10-year follow-up, the jaundice clearance rate at three months was 31.2%.
conclusionsWhile preoperative scoring systems showed limited predictive ability, postoperative APRI scores at three months emerged as a powerful predictor of long-term outcomes in BA patients. Our findings suggest that patients with three-month postoperative APRI scores > 1.12 should receive more intensive monitoring and earlier consideration for transplantation. The significant improvement in outcomes across three decades demonstrates the value of accumulated institutional experience and improved clinical management protocols in this challenging disease.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.